PPCB
Propanc Biopharma, Inc. Common Stock
NASDAQ: PPCB · HEALTHCARE · BIOTECHNOLOGY
$0.10
+2.40% today
Updated 2026-04-30
Market cap
$2.32M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$52.11
Dividend yield
—
52W range
$0 – $11
Volume
3.9M
Propanc Biopharma, Inc. Common Stock (PPCB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1,812.00%
ROA
-536.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | — | $-842000.00 | — | — | — |
| 2011 | — | $-2.15M | — | — | — |
| 2012 | — | $-11.43M | — | — | — |
| 2013 | — | $-1.44M | — | — | — |
| 2014 | $0.00 | $-829564.00 | — | — | — |
| 2015 | $0.00 | $-3.41M | — | — | — |
| 2016 | $0.00 | $-9.41M | — | — | — |
| 2017 | $0.00 | $-7.87M | — | — | — |
| 2018 | $0.00 | $-7.04M | — | — | — |
| 2019 | $0.00 | $-5.76M | — | — | — |
| 2020 | $0.00 | $-4.74M | — | — | — |
| 2021 | $0.00 | $-2.03M | — | — | — |
| 2022 | $0.00 | $-2.66M | — | — | — |
| 2023 | $0.00 | $-2.66M | — | — | — |
| 2024 | $0.00 | $-1.82M | — | — | — |
| 2025 | $0.00 | $-58.92M | — | — | — |